Lancet: Right-handed metomia does not reduce the risk of atrial fibrillation and delirium in patients after heart surgery.
-
Last Update: 2020-07-28
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Atrial fibrillation and delirium are common adverse events after heart surgery, right-hand mytomiasis as a sedative with unique properties that can reduce the risk of various complicationsRecently, researchers examined whether right-handed mytomia could reduce the incidence of new atrial fibrillation and delirium in patients after heart surgeryThe rate at which heart surgery performed on cardiopulmonary transcurrentsurgery in the United States increased to an hour after bypass transplantation in patients who underwent cardiopulmonary surgery and participants who were given a pre-surgery preoperative right-handed metormia or physiological saline placeboThe main results of the study were atrial fibrillation and delirium on the day after surgery or before discharge from the hospitalAmong the patients was the placebo group of the right-hand metomiaThere was no significant relative risk of adness relative to the case difference in the case of atrial fibrillation in the right-handed metamine group.) The incidence of delirium placebo was a relative risk of a right-handed metomyquine group increasing to no significant differenceSevere adverse events include cardiac palpitations (requires treatment) and low blood pressure, myocardial infarction, stroke, surgical site infection, pulmonary embolism, deep vein thrombosis, and deathAmong patients who took right-handed metomia in accordance with the clinician's judgment, a well-known () patient who took a placebo , a patient who had a severe adverse event died in each groupThe study concluded that the treatment of right-turned metatomlico, which lasts for hours from anaesthetic induction, did not prevent the incidence of postoperative atrial fibrillation and delirium in patients with heart surgery
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.